Evidence map›Paper›PMID 41291151›Full record

ArticleCommunications biology2025

TIPIN coordinates ATM-dependent checkpoint and NF-κB signaling to counteract DNA replication damage from topoisomerase inhibition.

Arafat Khan, Justin F Lim, Natalie Lo, Jinal A Patel, John Haley, Hyungjin Kim

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arafat KhanDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, USA.ORCID http://orcid.org/0000-0002-8810-2778
Justin F LimDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, USA.
Natalie LoDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, USA.
Jinal A PatelDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, USA.
John HaleyDepartment of Pathology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
Hyungjin KimDepartment of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, New York, USA. hyungjin.kim@stonybrook.edu.ORCID http://orcid.org/0000-0003-1913-6373

Funding

The interplay of TIMELESS and PARP1 in DNA replication fork stabilityR01GM144399 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI KIM, HYUNGJIN · 2022 to 2025
$1.4M
Roles of TIMELESS in oncogene-induced senescence and oncogenic transformationR01CA285515 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI Hyungjin Kim · 2024 to 2026
$1.1M
NCI NIH HHS R01 CA285515NIGMS NIH HHS R01 GM144399U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01CA285515U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01GM144399
6 · The paper itself

Abstract

ATM is an apical kinase that governs cellular responses to DNA replication-associated double strand breaks (DSBs) accumulated by the topoisomerase inhibitor anti-cancer therapy. Here we identify that TIPIN, a major constituent of the fork protection complex in the replisome, plays a key role in coordinating ATM signaling tied to DNA replication stress. We demonstrate that TIPIN amplifies ATM signaling to promote DNA end resection and homology-directed repair. TIPIN itself is phosphorylated by ATM, which is required for the recruitment of MDC1 to stalled forks to promote ATM-dependent NF-κB activation. Inhibition of the NF-κB pathway by MDC1 depletion impairs upregulation of anti-apoptotic regulator c-FLIP, thus potentiating caspase-8 activation and cytotoxicity of topoisomerase inhibition. Together, our study defines TIPIN as a master regulator of ATM-dependent DSB repair and NF-κB signaling. We propose that targeting MDC1, a key effector of ATM-TIPIN signaling, acts as a chemosensitizer that suppresses therapy-induced senescence and augments the effectiveness of genotoxic therapy.

Indexed as

Ataxia Telangiectasia Mutated ProteinsDNA DamageDNA ReplicationNF-kappa BTopoisomerase InhibitorsAdaptor Proteins, Signal TransducingCell Cycle ProteinsCell Line, TumorDNA RepairHumansSignal TransductionTrans-ActivatorsAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsMDC1 protein, humanNF-kappa BTopoisomerase InhibitorsTrans-Activators

Identifiers

PMID41291151
PMCPMC12647206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.